Shandong Weigao Medical Polymer Receivables 2012-2024 | SHWGF

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Shandong Weigao Medical Polymer receivables from 2012 to 2024. Receivables can be defined as the total amount of collectibles for a company

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Shandong Weigao Medical Polymer receivables from 2012 to 2024. Receivables can be defined as the total amount of collectibles for a company

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$205.7B
Stryker (SYK)	$140B
Boston Scientific (BSX)	$123.1B
Medtronic (MDT)	$115.5B
EssilorLuxottica (ESLOY)	$107.3B
Lonza Group Ag (LZAGY)	$45.5B
Haleon (HLN)	$44B
GE HealthCare Technologies (GEHC)	$39.7B
ResMed (RMD)	$35.9B
Terumo (TRUMY)	$28.3B
Koninklijke Philips (PHG)	$24.9B
Zimmer Biomet Holdings (ZBH)	$21.4B
Baxter (BAX)	$18.3B
Insulet (PODD)	$16.5B
Smith & Nephew SNATS (SNN)	$11B
Bio-Rad Laboratories (BIO)	$10.3B
BellRing Brands (BRBR)	$8.6B
Demant (WILYY)	$8.4B
Lantheus Holdings (LNTH)	$7.5B
ICU Medical (ICUI)	$4.2B
TG Therapeutics (TGTX)	$4.2B
Prestige Consumer Healthcare (PBH)	$3.7B
Haemonetics (HAE)	$3.7B
Envista Holdings (NVST)	$3.6B
Perrigo (PRGO)	$3.6B
Neogen (NEOG)	$3.1B
GN Store Nord (GNNDY)	$3B
QuidelOrtho (QDEL)	$2.6B
Agios Pharmaceuticals (AGIO)	$2.6B
Green Thumb Industries (GTBIF)	$2.2B